Abstract
Inflammation is a local tissue response to attacks characterized by vascular and cellular events, including intense oxidative stress. Riparin A, a compound obtained from Aniba riparia, has been shown to have antioxidant activity and cytotoxicity in vitro. This study was aimed at evaluating the anti-inflammatory effect of riparin A against acute inflammation. The results of our evaluations in various experimental models indicated that riparin A reduced paw edema induced by carrageenan, compound 48/80, histamine, and serotonin. Furthermore, it decreased leukocyte and neutrophil counts, myeloperoxidase activity, thiobarbituric acid reactive substance (TBARS) levels, and cytokine (tumor necrosis factor-α and interleukin-1β) levels increased by carrageenan-induced peritonitis, and reversed glutathione levels. Riparin A also reduced carrageenan-induced adhesion and rolling of leukocytes on epithelial cells and did not produce gastric-damage as compared with indomethacin. In conclusion, the data show that riparin A reduces inflammatory response by inhibiting vascular and cellular events, modulating neutrophil migration, inhibiting proinflammatory cytokine production, and reducing oxidative stress.
Keywords:
Inflammation; Neutrophil; Oxidative stress; Riparin.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Anti-Inflammatory Agents / isolation & purification
-
Anti-Inflammatory Agents / therapeutic use*
-
Antioxidants / isolation & purification
-
Antioxidants / therapeutic use
-
Benzamides / isolation & purification
-
Benzamides / therapeutic use*
-
Carrageenan / adverse effects*
-
Carrageenan / immunology
-
Cell Adhesion / drug effects
-
Cytokines / immunology
-
Edema / chemically induced
-
Edema / drug therapy*
-
Edema / immunology
-
Edema / pathology
-
Extremities / pathology
-
Immune System Diseases / chemically induced
-
Immune System Diseases / drug therapy*
-
Immune System Diseases / immunology
-
Immune System Diseases / pathology
-
Inflammation / chemically induced
-
Inflammation / drug therapy
-
Inflammation / immunology
-
Inflammation / pathology
-
Lauraceae / chemistry
-
Leukocyte Disorders / chemically induced
-
Leukocyte Disorders / drug therapy*
-
Leukocyte Disorders / immunology
-
Leukocyte Disorders / pathology
-
Leukocyte Rolling / drug effects
-
Male
-
Mice
-
Neutrophils / drug effects*
-
Neutrophils / immunology
-
Neutrophils / pathology
-
Oxidative Stress / drug effects
-
Peritonitis / chemically induced
-
Peritonitis / drug therapy*
-
Peritonitis / immunology
-
Peritonitis / pathology
-
Peroxidase / immunology
-
Phenethylamines / isolation & purification
-
Phenethylamines / therapeutic use*
Substances
-
Anti-Inflammatory Agents
-
Antioxidants
-
Benzamides
-
Cytokines
-
N-phenethylbenzamide
-
Phenethylamines
-
Carrageenan
-
Peroxidase
Supplementary concepts
-
Neutrophil Chemotactic Response, Abnormal